Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Adding Estonian national resource page #270

Merged
merged 23 commits into from Jan 24, 2024
Merged

Conversation

hedi-ee
Copy link
Contributor

@hedi-ee hedi-ee commented Jan 24, 2024

Creating a new national resources page for our beloved IDTk

hedi-ee and others added 19 commits January 23, 2024 15:31
Creating the Estonian national resources page
first draft with the links pasted in
Added info on National data sources
fixed indention
fixed formatting
fixed link formatting
further info and link fixing
added further info
dashboards
* Update estonia.md, add HB guideline links

added HB guinelines for health authorities and general public

* Update wastewater surveillance paragraph

* Update prevalence study

* added antibody surveillance

* Update korogenoest

* Update estonia.md
tiny formatting changes
added epidemic reviews info
added links to the surveillance initiatives
slight change somewhere
added more stuff on the health board
just editting
* Update estonia.md

* Update estonia.md
typo fixes
@hedi-ee hedi-ee requested a review from a team as a code owner January 24, 2024 11:56
added Estonia to the sidebar
made the page searchable
Copy link
Member

@martin-nc martin-nc left a comment

Choose a reason for hiding this comment

The reason will be displayed to describe this comment to others. Learn more.

Just a few quibbly little things in the comments!

## Disease surveillance initiatives
During the COVID-19 pandemic, the need for additional surveillance data became pressing. With scientists being able to ensure rapid development and implementation of new methodologies, the following initiatives were implemented in cooperation with the University of Tartu:

* [__Wastewater surveillance__](https://ut.ee/en/node/113141) was set up in August 2020 [by the researchers of the University of Tartu](https://ut.ee/en/node/113141) (prof Tanel Tenson and Veljo Kisand) and taken over [by the Health Board](https://www.terviseamet.ee/et/reoveeseire-kaardirakendus) in 2022. Based on data from Estonia, it was observed that the viral load in wastewater increased before a rise in the number of infected people was observed. Furthermore, in certain places such as dormitories and prisons, the viral load increase was used to predict outbreaks. In conclusion, wastewater studies had an additional value when infection rates were on the rise or decline, but not during a plateau.
Copy link
Member

Choose a reason for hiding this comment

The reason will be displayed to describe this comment to others. Learn more.

Maybe remove titles like "Prof". We probably don't know them all, and they change anyway.


* [__Wastewater surveillance__](https://ut.ee/en/node/113141) was set up in August 2020 [by the researchers of the University of Tartu](https://ut.ee/en/node/113141) (prof Tanel Tenson and Veljo Kisand) and taken over [by the Health Board](https://www.terviseamet.ee/et/reoveeseire-kaardirakendus) in 2022. Based on data from Estonia, it was observed that the viral load in wastewater increased before a rise in the number of infected people was observed. Furthermore, in certain places such as dormitories and prisons, the viral load increase was used to predict outbreaks. In conclusion, wastewater studies had an additional value when infection rates were on the rise or decline, but not during a plateau.
* [__Prevalence of SARS-CoV-2 IgG antibodies.__](https://covid19dataportal.ee/en/data_types/serology/data/) The determination of antibodies allowed for a retrospective assessment of the outbreak's extent and is an important tool for assessing the extent of population immunity. In Estonia, two seroepidemiological studies were conducted in the spring and late summer of 2020 (Koro-Sero-EST 1 end 2). Moving forward, the determination of antibodies was incorporated into the prevalence study.
* [__Prevalence study.__](https://ut.ee/en/content/study-prevalence-coronavirus-estonia) The primary objectives of active surveillance were to evaluate the widespread presence of SARS-CoV-2 and the prevalence of antibodies. The first stage of the surveillance study took place from April 22nd to 29th, 2020. Adults from all over Estonia were invited to participate in the study based on a random sampling. In total, 33 stages were carried out, each involving 2000 - 2500 participants. The percentage of infected individuals fluctuated from less than 1% during the first wave to over 10% during the fourth wave. Active surveillance provided the most objective overview of the extent of virus presence in Estonia. The first stages of the prevalence study have been published by [Uusküla et al 2022](https://doi.org/10.1016%2Fj.puhe.2022.02.004).
Copy link
Member

@martin-nc martin-nc Jan 24, 2024

Choose a reason for hiding this comment

The reason will be displayed to describe this comment to others. Learn more.

"...place from April 22nd to 29th, 2020": change the date format to "...from 22 to 29 April 2020."

* [__Prevalence of SARS-CoV-2 IgG antibodies.__](https://covid19dataportal.ee/en/data_types/serology/data/) The determination of antibodies allowed for a retrospective assessment of the outbreak's extent and is an important tool for assessing the extent of population immunity. In Estonia, two seroepidemiological studies were conducted in the spring and late summer of 2020 (Koro-Sero-EST 1 end 2). Moving forward, the determination of antibodies was incorporated into the prevalence study.
* [__Prevalence study.__](https://ut.ee/en/content/study-prevalence-coronavirus-estonia) The primary objectives of active surveillance were to evaluate the widespread presence of SARS-CoV-2 and the prevalence of antibodies. The first stage of the surveillance study took place from April 22nd to 29th, 2020. Adults from all over Estonia were invited to participate in the study based on a random sampling. In total, 33 stages were carried out, each involving 2000 - 2500 participants. The percentage of infected individuals fluctuated from less than 1% during the first wave to over 10% during the fourth wave. Active surveillance provided the most objective overview of the extent of virus presence in Estonia. The first stages of the prevalence study have been published by [Uusküla et al 2022](https://doi.org/10.1016%2Fj.puhe.2022.02.004).
* [__SARS-CoV-2 sequencing__](https://kliinilinemeditsiin.ut.ee/et/sisu/eesti-sars-cov-2-taisgenoomide-jarjestamine-ja-analuus-korogeno-est-1est-2est-3) was initiated at the University of Tartu in 2020. The KoroGenoEst projects 1-3, also described as a [Showcase](https://www.infectious-diseases-toolkit.org/showcase/korogenoest), led by the University of Tartu, continued their operations up until January 2023. Over three years, a total of 8,990 samples were analyzed. From 2023 onwards, the Health Board assumed responsibility for the sequencing analysis of SARS-CoV-2.
* [__HOIA__](https://e-estonia.com/estonias-coronavirus-app-hoia-the-product-of-a-unique-private-public-partnership/) was a COVID-tracking app launched in August 2020. The app tracked contacts by capturing Bluetooth signals from nearby phones. If the signal was close and frequent enough, anonymous codes were collected and stored on the phone. If a person with the HOIA app became infected, they could alert the app, and those who were considered to have been in close contact with that person were immediately notified. The app was used by 300 000 people but was decommissioned in May 2022.
Copy link
Member

Choose a reason for hiding this comment

The reason will be displayed to describe this comment to others. Learn more.

"300 000" => "300,000"?

* [__SARS-CoV-2 sequencing__](https://kliinilinemeditsiin.ut.ee/et/sisu/eesti-sars-cov-2-taisgenoomide-jarjestamine-ja-analuus-korogeno-est-1est-2est-3) was initiated at the University of Tartu in 2020. The KoroGenoEst projects 1-3, also described as a [Showcase](https://www.infectious-diseases-toolkit.org/showcase/korogenoest), led by the University of Tartu, continued their operations up until January 2023. Over three years, a total of 8,990 samples were analyzed. From 2023 onwards, the Health Board assumed responsibility for the sequencing analysis of SARS-CoV-2.
* [__HOIA__](https://e-estonia.com/estonias-coronavirus-app-hoia-the-product-of-a-unique-private-public-partnership/) was a COVID-tracking app launched in August 2020. The app tracked contacts by capturing Bluetooth signals from nearby phones. If the signal was close and frequent enough, anonymous codes were collected and stored on the phone. If a person with the HOIA app became infected, they could alert the app, and those who were considered to have been in close contact with that person were immediately notified. The app was used by 300 000 people but was decommissioned in May 2022.

## Dashboards and visualization platforms
Copy link
Member

Choose a reason for hiding this comment

The reason will be displayed to describe this comment to others. Learn more.

"visualization" => "visualisation" (British English!)


## Dashboards and visualization platforms

* [koroona.ut.ee](https://koroona.ut.ee/) Multiple dashboards using open data provided by the Health Board.
Copy link
Member

Choose a reason for hiding this comment

The reason will be displayed to describe this comment to others. Learn more.

Maybe make this format:
[Platform name]: blurb
So the name of the platform, then a colon, then the blurb starting with a lowercase letter.


## Regulations
<!--- Ethical and legal regulations in the country, committees, etc --->
In Estonia, a research plan that involves human subjects needs to be approved by an ethics board. The two general ethics boards that researchers can apply to are [(Research Ethics Committee of the University of Tartu](https://ut.ee/en/node/113848) and [Research Ethics Committee of the National Institute for Health Development](https://en.tai.ee/en/about-us/tallinn-medical-research-ethics-commitee).
Copy link
Member

Choose a reason for hiding this comment

The reason will be displayed to describe this comment to others. Learn more.

An extra "(" in the first part of the link. Should be: Research Ethics Committee of the University of Tartu

@martin-nc martin-nc merged commit e3a444b into elixir-europe:main Jan 24, 2024
4 checks passed
Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment
Projects
None yet
Development

Successfully merging this pull request may close these issues.

None yet

5 participants